Cover Image

Net clinical benefit of anticoagulation therapy in the elderly patients with atrial fibrillation

Lorenzo Palleschi, Eleonora Nunziata
  • Lorenzo Palleschi
    Hospital S. Giovanni-Addolorata, Unit of Geriatrics, Italy


Old age remains one of the strongest risk factors for stroke in patients with atrial fibrillation (AF). Oral anticoagulation (OAC) is the most effective way to prevent thromboembolic disease in patients with atrial fibrillation (AF). Until few years ago, aspirin and vitamin-K antagonists (VKAs) were the primary agents used to prevent thromboembolic disease in patients with AF. The approval of non–vitamin K oral anticoagulants (NOACs) has now expanded the range of therapeutic agents available to providers. The authors highlight practical considerations regarding the selection and use of OAC in older adults to aid clinical decision making.


Atrial fibrillation; oral anticoagulation; stroke; elderly.

Full Text:

Submitted: 2018-04-27 09:12:44
Published: 2018-06-07 14:54:30
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Copyright (c) 2018 Lorenzo Palleschi, Eleonora Nunziata

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© PAGEPress 2008-2019     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy